NFE2L2 and chronic kidney disease: Sulforaphane also activates nuclear factor-erythroid 2-related factor 2 (Nrf2) and indirectly suppresses nuclear factor-κB (NF-κB) activity, exhibiting a salutary effect in CKD, an important VC risk factor [53].